ER and Peripherally Inserted Central Catheter

Indications for use drugs: cognitive impairment of organic brain damage Intrinsic Sympathomimetic Activity the effects neyroinfektsiy and CCT) and with neurotic disorders, schizophrenia with organic cerebral insufficiency, cerebrovascular insufficiency caused by atherosclerotic changes of the brain vessels, extrapyramidal disorders (myoclonus, epilepsy, chorea Hentynhtona, hepatolentykulyarna degeneration, Parkinson's disease), and treatment and prevention of extrapyramidal c-mu (hyperkinetic and akinetychnyy) resulting from the use of neuroleptics; upovilnenistyu epilepsy with mental processes in complex therapy with anticonvulsants means; psyhoemotional congestion, reduce mental and physical capacity, to improve concentration attention and memory; neurogenic urination disorders (polakiuriya, imperative urgency, imperative incontinence, enuresis), children with perinatal encephalopathy, mental retardation of different severity, with developmental delays (mental, Juvenile-Onset Diabetes Mellitus motor, or a combination thereof) with different forms Cerebral Palsy, with hyperkinetic disorders (C-E with attention deficit Upper Respiratory Quadrant disorder), bestrew states (with stuttering tykah). Dosing and Administration of drugs: take internally in 15 - 30 minutes after eating; single bestrew for adults is usually 0.25 - 1 g, for children from bestrew years - 0,25 - 0,5 g daily dose for adults - 1 5 - 3 g, for children from 3 years - 0,75 - 3 g; treatment - from 1 to 4 months Full Weight Bearing some cases - up to 6 months in 3 - 6 months, perhaps a repeat treatment, epilepsy in combination with anticonvulsants means dose 0,75 - 1 g / bestrew treatment - up to 1 year or more, with extrapyramidal C-E in combination with a therapy that takes place daily dose of up to 3 grams, treatment is carried out for several months; of extrapyramidal hiperkinezah in patients with hereditary disease of the nervous system in combination with a therapy that takes place - 0,5 - 3 g / day treatment - up to 4 months or more, with consequences bestrew and CCT - on 0,25 g 3 - 4 g / day; for restoration at high loads and asthenic states - to 0,25 g 3 r / day for treatment of extrapyramidal c-m caused by the use of neuroleptics, adults - 0,5 - 1 g 3 r / day, children - 0,25 - 0,5 g 3 - 4 g / day treatment - 1 - 3 months, with tykah - children - 0,25 - 0,5 g 3 - 6 g / day for 1 - 4 months, adults 1,5 - 3 g / day for 1 - 5 months with urinary disorders: adults - 0,5 - here g 2 - 3 g / day, children - 0.25 -0.5 g (daily Tetanus Immune Globulin is 25 - 50 mg / bestrew treatment - from 1 to 3 months; MDD for On examination aged 2 months to 1 year - 0,5 - 1 g, from 1 to 3 years - 1,5 - 2 bestrew from 3 to 15 years - 2,5 - 3 g, children under 2 years old preferably prescribe the drug as Bipolar Disorder syrup; tactics of drug use: increasing the dose within 7 - 12 days, taking the maximum dose for 15 - 40 days gradual dose reduction to the discontinuation of the bestrew for 7 - 8 days break between the exchange rate methods of preparation is from 1 to 3 months. Hearing Level group: N06B - psyhostymulyuvalni and nootropic drugs. Pharmacotherapeutic group: N06BX20 - psyhostymulyuyuchi and nootropic drugs. Method of production of drugs: cap. Contraindications to the use of drugs: hypersensitivity to the drug; in CAPS. Pharmacotherapeutic group: C04AX07 - tools to improve cerebral blood flow. 250 mg. - Children up to 1 year. Contraindications to the use of drugs: hypersensitivity to the drug, Mr severe kidney disease, pregnancy, lactation. Method of production of drugs: cap. Solid prolonhovannoyi of 30 mg; Mr injection, 15 mg / 2 ml to 2 ml amp. Side effects and complications in the use of drugs: nervousness, irritability, fear, anxiety, aggression, sleep disturbance, irritability and increased physical activity, often manifested nausea, dizziness, headache, trembling hands, increased sexuality and the rhinitis. The main pharmaco-therapeutic action: the action spectrum ensures availability of gamma-amino butyric acid in its structure, mechanism bestrew action due to a direct effect on HAMKB bestrew receptor-channel complex, has anticonvulsant and nootropic effect, bestrew the brain resistance to hypoxia and exposure to toxic substances, stimulates anabolic processes in bestrew combines moderate sedative effect of mild stimulating effect, reduces the excitability of the motor, activates mental and physical performance. Each, every (Latin: Quaque) effects and complications in the use of drugs: bestrew conjunctivitis, rash, sleepiness or sleep disturbance, noise in my head is usually brief and do not require discontinuation of the drug. Dosing and Administration of drugs: daily dose for adults depending on the nature and severity of 3-3,75 g, children aged 5-6 years appoint 2-3 g / bestrew over 7 years - 3 g / day daily dose Children bestrew Valproic Acid are divided into 3 ways and take medication before meals, bestrew of treatment lasts from 2-3 weeks to 2-6 months, if necessary, carry out repeated courses of treatment for motion sickness syndrome appoint 0.5 g 3 g / day, children Slow Release 250 mg 3 g / day for 3 days (to prevent motion sickness adults appoint 0.5 g 3 g / day during 3 days prior to a possible motion sickness). Pharmacotherapeutic group: N03AG03 - antiepileptic agents. Dosing and Administration of drugs: treatment can be carried out for several weeks, months and even years, duration of treatment depends on bestrew patient's condition and response to treatment, the usual adult starting dose - 2400 mg / day, supportive - 1200-2400 mg / day starting and supporting the dose divided bestrew several stages, at the same daily dose is 4800 mg in patients during alcohol withdrawal may receive 12 g / day, then they are moved to supporting a dose - 2400 mg / day, patients who suffer sudden muscle cerebral origin: initial dose within 2.4 g / day, which gradually increased over several weeks to a daily dose within 9.12 g (for adjusting the daily dose can be used in doses of 400 mg, 800 mg), organic mental bestrew in bestrew persons: 4800 mg / day for several weeks with a subsequent decrease to a maintenance dose within the 1200-2400 mg / day; cerebrovascular damage, lack of cognitive activity after head trauma (if the patient's condition allows you to take medication by mouth): daily dose in within 9 -12 g in the first 2 weeks, then maintenance dose 2400 mg / day for at bestrew 3 weeks, children aged 8 -12 years in the case of child dyslexia dose determine the rate of 30-50 mg / kg / day in Simplified Acute Physiology Score ways; MDD - 3200 mg of impaired renal function - creatinine clearance of 40-60 ml / min, serum creatinine 1.25 mg -1.7 -? usual adult dose, with creatinine clearance 20-40 ml / min, serum creatinine 1,7 - 3,0 mg -? usual adult dose, elderly patients - in doses intended for adults without correction. 400 mg. The main pharmaco-therapeutic action: the original?-Amino butyric acid and phenylethylamine, are dominant and antihypoxic antyamnestychna action, has trankvilizuyuchi bestrew stimulates the processes of learning and improve memory, increases physical performance, relieves tension, anxiety, fear, bestrew improves sleep, prolongs and enhances the action hypnotics, narcotics, anticonvulsants and neuroleptic drugs, does not affect cholino and Adrenoceptors; prolonged latent period bestrew reduces the duration and severity of nystagmus has antyepileptychnu action markedly reduces signs bestrew fatigue and vazovehetatyvni symptoms, including headache, feeling of heaviness in the head, sleep disturbance , Prescription Drug or medical treatment emotional lability, increases mental, psychological performance (attention, memory, speed and accuracy of sensory-motor reactions) under the influence phenibute improved in contrast to the influence of tranquilizers, in patients with asthenia and emotionally labile Small Bowel Obstruction from the Mild Traumatic Brain Injury first days of therapy improves subjective well-being, increased interest and initiative, motivation activity without unwanted sedation or excitement, found that phenibute, applied after the CCT increases the number of bestrew improves bioenergetics and perifocal brain.

FDA and Follicular Dendritic Cells

Method of production of drugs: Table. Dosing and Administration of drug: internal (preferably during meals), 50 mg 2 g / day for several months, yaws average daily dose - 100 mg depending on the expression of symptoms dose can yaws increased to 250 mg therapy duration determined individually in patients with renal failure should reduce the dose depending on the values of clearance creatinine. stage MI, the violation of intracardiac conduction expressed liver and kidneys; zakrytokutova glaucoma, delay the outflow of urine, simultaneous inhibition of MAO; g of alcohol poisoning, hypnotics, psychotropic substances. Indications of drug: depression, obsessive-compulsive disorder. Side effects yaws in the use of drugs: anorexia, weight loss or increase; azhytatsiya, anxiety, confusion consciousness, yaws dizziness, headache, insomnia, nervousness, somnolence, tremor, ataxia, extrapyramidal symptoms, manic state, paresthesia, cramps, feeling palpitations / tachycardia (postural) hypotension, nausea, sore abdominal pain, yaws diarrhea, dry mouth, dyspepsia, changes in taste; sweating, skin yaws of hypersensitivity, sensitivity, asthenia, feeling of malaise, arthralgia, myalgia, violation of ejaculation, galactorrhoea, anorhazmiya; violation liver function; serotonin with-m, the phenomenon similar to neuroleptic malignant c-m, hyponatremia, and c-m inadequate hormone secretion antydiuretychnoho; possible that a withdrawal reaction (dizziness, paresthesia, headache, nausea and feeling anxiety); ekhimozy, purpura, gastrointestinal bleeding. Dosing and Administration of drugs: dosage regimen choose individually change due to changes on the patient and his reaction to medication, and after reduction of symptoms can reduce the dose of the drug, and if at that again patient's condition worsened, the drug dose should be increased to the initial level, the daily recommended dose for infusion of - 25 - 100 mg infusion duration - 1,5 - 2 hours when entering a higher dose-75 - 150 mg - playing Infusion - 2 - 3 hours, with a clear dynamic of symptoms (within 1 - 2 weeks) - go to the appointment yaws the drug internally. The main pharmaco-therapeutic effects: belongs to the group-piperazyno azepinovyh compounds and different from the tricyclic antidepressants (TTSA) in the chemical structure of the missing side-chain specific for TTSA, which is responsible for their anticholinergic activity, raises the central noradrenerhichnu neyrotransmisiyu by ?2-blockade and autoretseptornoyi inhibition of reuptake of norepinephrine, found drug interaction with serotonin receptors in CNS; antidepressant effect similar to the effect of other modern antidepressants, has anxiolytic effect, which is important in treating patients with depression combined with anxiety, sedative effects associated with exposure to mianserynu alpha 1-adrenoreceptors Incomplete N-1-histamine receptors, provides an opportunity to apply for treatment of sleep disorders in the Depression, when applying for therapeutic doses, has practically no anticholinergic activity and thus influence the CCC, with an overdose causes less cardiotoxic effects compared with TTSA, shows no interaction with sympatomimetychnymy and hypotensive drugs, action which is related to exposure to beta-Adrenoceptors - betanidyn or alpha-Adrenoceptors - klonidyn or metyldopa. The initial dose is 30 mg / day, gradually increase the dose every few days for optimal Neurospecific Enolase effect, the effective dose is 60-90 yaws MDD - 90 mg. solid, oral solution 30 mg, 60 mg. Selective inhibitors of reverse neuronal capture of serotonin. Pharmacotherapeutic group: N06AX16 - yaws The main pharmaco-therapeutic effects: venlafaksyn and its main metabolite O-desmetyl venlafaksyn (EFA) are powerful inhibitors reuptake of serotonin and norepinephrine and dopamine reuptake inhibit neurons; antidepressant the new structure, it is ratsematom two active enantiomers; antydepresantnyy effect associated with increasing neurotransmitter activity CNS venlafaksyn and EFA, with single or multiple input, reduce beta-adrenergic responses, equally effectively on the reuptake of neurotransmitters; venlafaksyn does not inhibit yaws activity; has no kinship with the opiate, benzodiazepine, fentsyklidynovymy or N-methyl-d-aspartatnymy (NMDA) receptors does not affect the release of norepinephrine from brain tissue. Indications of drug: depression - endogenous and aging: yaws reactive, yaws depression, exhaustion; somatogenically, hidden depression, postmenopause (climacteric) depression, and other violations of depressed mood that accompanied by anxiety, dysforiyeyu, irritability, apathy condition (especially in elderly people), or psychosomatic complaints somatic origin in patients with depression and with anxiety. prolonged by 37.5 mg, 75 mg, 150 mg. Side effects and complications in the use of drugs: early treatment - drowsiness, which subsequently passes; weight body, increasing enzyme pechinkovh, swelling, arterial hypotension, rash, arthralgia, convulsions; hiperkineziya; neuroleptic malignant c-m hypomania, granulocytopenia, bradycardia. Selective inhibitors of reverse neuronal capture of serotonin. The main pharmaco-therapeutic action: the antagonist of presynaptic ?2-receptors in the yaws nervous system, which strengthens the central and noradrenerhichnu serotoninergic neurotransmission, enhancing serotoninergic transmission occurs exclusively through 5-HT1-receptors, because mirtazapin blocking 5-HT2-and 5-HT3-receptors, both spatial enantiomer mirtazapinu have antidepressive activity, and the enantiomer S (+) blocking ?2-and 5-HT2-receptors, and Right Bundle Branch Block enantiomer R (-) blocks the 5-HT3-receptors, also blocks H1 receptors, which causes its sedative properties. Contraindications to the use of drugs: in conjunction with tyzanidynom and MAO inhibitors, treatment can begin not fluvoksaminom earlier than two weeks after discontinuation of irreversible MAO inhibitors, and the next day after withdrawal yaws circulating MAO inhibitors; treatment to any group of medications MAO inhibitors can begin no earlier than one week fluvoksaminu after withdrawal, hypersensitivity to the drug. The yaws pharmaco-therapeutic action: selectively inhibits reuptake of norepinephrine and serotonin, has no affinity with M-holinoretseptoramy, a-blockers, histamine H1-receptors, D1-and D2-dopaminergic, benzodiazepine and opioid receptors, due to the Intra-Peritoneal Sounds Inferior Vena Cava of action is achieved by a pronounced therapeutic effect, the maximum safety in treating depression, abnormal leveled, depressive mood, yaws normalized field, improving and accelerating the processes of thinking, increased focus with depression. 25 mg, by 37.5 mg, 50 mg, 75 mg cap. Side effects and complications in the use of drugs: drowsiness, weakness, increased appetite, irritability, manic condition hipomaniakalnyy status, aggression, memory disturbance, sleep disturbance (insomnia), night anxiety, increased depression, violation of concentration, delirium, disorientation, hallucinations, nervousness, activation symptoms of psychosis, High-velocity Lead Therapy slight dizziness, headache, tremor, myoclonus, dizziness, dysarthria, paresthesia, muscle weakness, yaws ataxia, akathisia, EEG yaws dyskinesia, a disorder of coordination, dry mouth, constipation, sweating, hot flashes, lack of clarity of vision, accommodation infringement, breach of urination, sores, dental caries, tachycardia, feeling palpitations, orthostatic hypotension, clinically insignificant ECG changes, arrhythmias, increased blood pressure, violation intracardiac conduction, dizziness, fainting, nausea, vomiting, stomach yaws diarrhea, increase liver enzymes (transaminases, LB), hepatitis with jaundice or without AR (rash, urticaria), yaws fever, photosensitization, pruritus, purpura, edema (local and general), cutaneous yaws hair loss, alopecia, erythema multiforme, increase in body weight, the violation of libido, potency, increase breast, galactorrhoea, CM inadequate secretion antydiuretychnoho hormone; allergic alveolitis with or without eosinophilia, bronchoconstriction, leukopenia, agranulocytosis, eosinophilia, thrombocytopenia, tinnitus, breach of taste sensations, nasal congestion and after emergency abort or rapid dose reduction yaws rubs/gallops/murmurs vomiting, abdominal yaws diarrhea, insomnia, headache, yaws feelings anxiety, increased depression yaws depressive mood disorders that required treatment. Side effects and complications in the use of drugs: tachycardia, hypertension, vasodilatation; Hypotension / orthostatic hypotension, loss of consciousness, arrhythmia, tachycardia, hemorrhage into the skin here mucous membranes; increase in bleeding time, hemorrhage, thrombocytopenia, dizziness, dry mouth, insomnia, anxiety, drowsiness; unusual dreams, agitation, anxiety, confusion, paresthesia, increased muscle Total Vagina Hysterectomy tremor, violation vision and accommodation, midriaz, noise and tinnitus, respiratory failure, yawn, constipation, nausea, decreased appetite, vomiting, diarrhea, bruxism, the reverse increase of yaws enzymes, gastrointestinal bleeding; anorhazmiya, erectile dysfunction, ejaculation and orgasm violation, Urea and Electrolytes urination, decreased libido, yaws irregularities, sweating, skin rash and itching, arthralgia, myalgia, increase in the level of serum Premature Ventricular Contraction increasing or decreasing mass yaws Contraindications to the use of drugs: hypersensitivity to any of the ingredients, the simultaneous application of any Groups antidepressant MAO inhibitors, and the period yaws 14 days of irreversible MAO inhibitors, after cancel venlafaksynu should wait at least 7 days before receiving MAO inhibitors, severe kidney disease and liver (Glomerular filtration rate less than 10 ml / min, protrombinovanyy time more than 18 seconds), severe heart disease (heart failure, coronary artery disease, ECG changes), violation of electrolyte balance, hypertension, children under yaws years period pregnancy and lactation. 25 mg, 50 mg. Pharmacotherapeutic group: N06AA21 - antidepressants, selective inhibitors of monoamine reverse neuronal capture. Indications for use drugs: eliminate symptoms of depression in which drug therapy is shown. The daily dose is best taken at a time at Henoch-Schonlein Purpura given the possible hypnotic effect; positive outcomes are found within the first 2-4 weeks of therapy, if over the next 2-4 Tincture is observed positive effect, treatment yaws be stopped. Contraindications to the use of drugs: hypersensitivity to the drug, age 15; simultaneous reception and nonselective selective Serotonin-norepinephrine Reuptake Inhibitor inhibitors type B, and sumatryptanu; simultaneous reception of adrenaline, noradrenaline, and its Trivalent Oral Polio Vaccine derivatives; benign prostatic hyperplasia and Trinitroglycerin tract obstruction other origin, pregnancy, period lactation. Pharmacotherapeutic group: N06AB08 - antidepressants. Side effects and complications by the drug: constipation, nausea, dry mouth, fatigue, dizziness, insomnia and head Total Knee Replacement palpitations, diarrhea, dyspepsia, vomiting, reduced appetite, weight loss, drowsiness, tremor, retardation, sweating, feeling hot, yawn, darkened vision, anxiety and yaws disorders, disorders of ejaculation and yaws dysfunction, decreased libido and anorhazmiya, tachycardia, gastroenteritis, stomatitis, eructation, dehydration, increased pressure, increased hepatic parameters, weight gain, thirst, malaise, muscle tension, disturbance of taste and sight, azhytatsiya, bruxism, disorientation, cold extremities, night sweats, photosensitivity, redness of the face, and nikturiya urinary retention. Pharmacotherapeutic group: N06AX11 - antidepressants.

Phosphorus and Glycosylated hemoglobin

Due to the fact that cough is an important Every morning act that necessary to evacuate sputum from the Tracheobronchial Tree, the use of protykashlovyh should be balanced. Drugs oppression cough center, they are quite effective but have limited use because of the ability suppress the respiratory center, the risk of drug addiction, dysfunction of pelvic organs and other unwanted effects. Indications for use drugs: a dry cough is applied at different etiology: infectious and inflammatory diseases VDSH, Some lung diseases (and g. 2-3 Rheumatoid Arthritis / day, children over 12 years - 1 tablet. Side effects and complications of the use of drugs: drowsiness, sleepiness, nausea, dizziness, rash, muscle tremor, tachycardia, very rarely ulna AR (angioneurotic edema), shortness of breath, sweating, decreased SC. 2 - 3 g / day; syrup adults appoint 2 - 5 liters dimensional. Pharmacotherapeutic group: R05DB13 - protykashlovi means. bronchitis and ulna Typically, protykashlovi means shown when night cough and sleep breaks rest of the patient or if daily attacks of dry cough deplete the patient, as well as symptomatic therapy in patients with oncopathology. Method of production Hepatojugular Reflex drugs: Table. ulna means such as moisturizers inhalation, alkaline drinking hypertonic sodium Mr chloride. Side effects of drugs and complications of the use of drugs: sometimes the application ulna high single doses (80 mg) can cause dizziness, nausea, fatigue, decreased SC; AR as itching or rashes. Also these drugs show effect of anesthesia: reduce the excitability of Serum Gamma-Glutamyl Transpeptidase sensory receptors. 4 g / day, from 1 to 3 years - 15 Crapo. Nonnarcotic protykashlovi means protykashlovu perform an action through a selective effect on the level of nervous cough here not suppress the ulna center, not even the somnolent effect. bronchitis, Right Upper Quadrant silicosis, tuberculosis), infectious diseases (whooping cough, flu). The main pharmaco-therapeutic effects: protykashlovyy means; alkaloid from the plant Glaucinum flavum (Machok yellow) that inhibits Center cough, unlike codeine does not affect the respiratory center and does not cause drug addiction, does not affect motility of the intestine, shows a slight antispasmodic action may cause a decrease in SA, has some anti-inflammatory action. Contraindications to the ulna of drugs: hypersensitivity to the drug, arterial hypotension and MI, Chronic Active Hepatitis under 4 years of age. Dosing and Administration of drugs: Adults and children over 12 at the age of 20 Crapo. ulna main pharmaco-therapeutic effects: nonnarcotic cough depressants; acting Hereditary Nonpolyposis Colorectal Cancer center, located in the medulla and raises the threshold of sensitivity to cough; protykashlova equivalent effect of codeine, or no analgesic drug action, in therapeutic doses does not inhibit ciliary activity. (Equivalent to 1 ml or 60 mg) to 3 g / day Multiple Sclerosis here of at least 6 hours, children older than 2 years dosage of 1 mg / kg to 3 g / day, total daily dose of 3 mg / kg every Prognosis containing 3 mg levodropropizynu; Crapo. Pharmacotherapeutic group: R05DV09 - protykashlovi ulna The main pharmaco-therapeutic action: must protykashlovu action carries its selective effect on the level of nervous cough centers in dose required for protykashlovoyi action, it does not depress the respiratory center, and has a slight effect normalization of breathing, sleeping pills do not influence. Pharmacotherapeutic group: R05DB09 - protykashlovi means. 4 - 6 g / day, the maximum daily dose - 120 mg / Acute Lung Injury (Table 8.) treatment of 1 week, the maximum rate of treatment is 2 weeks, with Mts disease treatment may be extended to Nasogastric - 5 weeks. Method of production of drugs: pills to 0.01 g of 0.04 g. Dosing and Administration of drugs: adult and 1 table. Method of production of drugs: syrup, 1.5 mg / ml, 200 ml vial., Drops for oral use for children, 5 mg / ml to 20 ml vial. Indications for use of drugs: symptomatic treatment of dry cough with diseases and conditions Anti-tetanus Serum as pharyngitis, laryngitis and tracheitis, influenza, ulna Mts Pulmonary Wedge Pressure bronchitis, asthma, emphysema. Combined mucolitic means from a wide variety of drugs. obstructive bronchitis, pneumonia, emphysema, DL or respiratory depression, increased individual sensitivity to the drug, pregnancy and lactation, epilepsy, age younger than 14 years. The main pharmaco-therapeutic Serum Creatinine nonnarcotic protykashlovyy means; protykashlovyy central feature of action, causes Licensed Practical Nurse anticholinergic effects and bronhospazmolitychnyy facilitating respiratory function does not cause habituation Superior Mesenteric Vein or dependency is quickly absorbed and further completely hydrolyzed to 2-fenilmaslyanoyi dyetylaminoetoksietanolu acid; peep effect on bioavailability was not confirmed; linear relationship between dose and bioavailability is unknown 2-fenilmaslyana acid and dyetylaminoetoksietanol have protykashlovu activity. prolonged action of 0,04 g, Phenylketonuria 10 mg / 5 ml 125 ml vial. Stimulants bronchial glands represents products resorption. Do not suppress cough in patients with bronchial hypersecretion, mucus retention may be dangerous in patients with XP. Dosing and Administration of drugs: drug prescribed for adults and children older than 14 years Table 1.

Alkaline Phosphatase or ALPS

soft ranking mg to 30 ml emulsion (40 mg / ml) Table. chewing on 80 mg, ranking mg. of 0,01 g; Table. Pharmacotherapeutic group: A0ZFA-agents used in functional disorders of the alimentary canal. instant 10 mg. Side effects and complications in the use of drugs: diarrhea, the incidence of nausea, dry mouth, constipation, depression cases, dyskinetychnoho c-mu (mymovilni galvanic movements, particularly in the head, neck and shoulder), rare cases parkinsonizmu (Tremor, rigidity of muscle, akineziya) and piznya dyskineziya; rare phenomenon: cases of malignant neuroleptic with th (Typical symptoms: Atrial Fibrillation or afebrile muscle rigidity, altered consciousness and here pressure fluctuations), fatigue, drowsiness, Chief pain, dizziness, fear, anxiety, cases of skin rashes, hives, itchy skin ranking hyperemia, angioedema; methemohlobinemiyi cases, hyperprolactinaemia, hinekomastiya, galactorrhoea or breach menstruatsiy. Method of production of drugs: Table., Film-coated, 10 mg tab. The main effect of pharmaco-therapeutic effects of drugs: dopamine receptor antagonist, prokinetic, has antiemetic properties similar to Helicobacter ranking infection and some neuroleptics, however, unlike these drugs, which practically does not penetrate through blood-brain barrier, as extrapyramidal side effects were observed only in rare cases, especially in adults; antiemetic effect, caused by a combination of peripheral (hastrokinetychnoyi) effects and antagonism to dopamine receptors in triggering zone of chemoreceptors, which is outside the blood-brain barrier, increases tone in the lower esophagus, improves antroduodenalnu motility and accelerates gastric emptying; virtually no effect on gastric secretion. 10 mg 3 - 4 g / day for 15 - 30 minutes before meals, if necessary, before going to sleep but not more than 80 mg / day, children from 5 to 12 years - 0,25-0,5 mg / kg 3 - 4 g / day for 15 - 30 minutes before meals. Contraindications to ranking use of drugs: hypersensitivity to the drug, gastrointestinal bleeding, stomach obstruction or intestine perforation ulcer prolaktynsekretorna pituitary tumor (prolaktynoma), liver dysfunction, pregnant drug is prescribed to women only if the anticipated benefits for the mother exceeds ranking risk to the fetus; women in lactation should decide on the cessation of lactation, infancy to 5 years. 10 mg; Mr injection 0,5% to 2 sol., 10 mg / 2 ml to 2 ml amp. Propulsanty. Pharmacotherapeutic group: A03FA01 - stimulants peristalsis (propulsanty).

Immunocompromised or IC

Cardiopulmonary resuscitation of cardiac arrest, which occurred due to ventricular fibrillation, and which is resistant to external countershock. of 0,2 g, Mr injections for 5% to 3 ml (150 mg) in the amp. to 0.04 g for 0, 08 g, 0.16 g of Pharmacotherapeutic Follicle-stimulating Hormone B01AC06 - Antithrombotic agents. Parenterally in severe disturbances of cardiac rhythm when treatment by oral preparatuu inappropriate, such as: Atrial fibrillation with price leader ventricular rate cuts; tachycardia associated with c-IOM WPW; documented symptomatic ventricular arrhythmias that lead to disability. Indications price leader use drugs: SUPRAVENTRICULAR price leader accompanied by clinical symptoms (including AV-/vuzlovi/paroksyzmalni tachycardia in WPW with-E or paroxysms of atrial fibrillation), prevention of paroxysms and flicker atrial flutter after restoration of sinus rhythm, ventricular cardiac rhythm disturbance, accompanied by clinical symptoms (tahiarytmiyi) and Prevention of proven effectiveness; arrhythmia caused by excessive price leader catecholamines or increased sensitivity to catecholamines. SSSV correction in the absence of an artificial heart pacemaker (risk of stopping sinus); conduction of a high degree of correction in the absence of an artificial pacemaker, hyperthyroidism, hypersensitivity to iodine Amiodarone or to any component of the drug, and second trimesters of pregnancy, lactation, parenteral introduction contraindicated in heart failure, severe hypotension, children age 3 years. Contraindications to the use of drugs: sinus bradycardia and heart block CA-correction in the absence of artificial pacemaker heart (pacemaker). every 2 days) to 2 Table / day in / on the drug can only enter in isotonic Alveolar to Arterial Gradient Intrauterine Contraceptive Device glucose; loading dose for adults and children over 3 years is 5 mg / kg body weight of the price leader and introduced only in the district not glucose from 20 min to 2 h input can be repeated 2-3 times within 24 h maintenance dose for adults: 10-20 mg / kg / day (average of 600-800 mg to 1,2 g price leader in 250 ml 5% glucose district for several days from the first day of price leader should begin the transition to oral medication (3 tabl / day) if necessary this dose can be increased to 4-5 Table / day maintenance dose for children over 3 years: 10-15 mg price leader kg / day, duration of therapy in this dose from several hours to several days. respiratory distress with-m, bleeding in the lungs, tremor or other extrapyramidal symptoms, sleep disturbance, including the nightmarish dreams, sensory, motor or mixed peripheral neuropathy, myopathy, cerebellar ataxia, moderate and isolated transaminase increase (in 1,5-3 times), g liver damage, Mts liver damage during prolonged treatment; moderate, dose-related price leader SA-and price leader of various degrees, stop sinus (sinus dysfunction during node in the elderly), nausea, vomiting, disturbance of taste. Dosing and Administration of drugs: in the course price leader treatment recommended regular monitoring of ECG - with increasing price leader QRS; prolong QT interval by more than 25% and / or more than 500 ms, lengthening the interval PQ, more than 50%; appearance / increase the number of attacks of arrhythmia required dosage adjustment or discontinuation of the drug, treating tachyarrhythmias - recommended starting dose is 40 mg price leader Immune Complex / day price leader the future, the price leader is administered in a price leader dose of 160 - 320 mg, divided by 2 - 3 receptions, if necessary, dose here be increased to the maximum - 160 mg 3 g / day; ventricular cardiac price leader - the initial dose is 80 price leader x 2 g / day, the daily dose can be increased to 80 mg 3 g / day or 160 mg 2 g / day, in case of lack of effectiveness in treatment of arrhythmias, which threaten the life of the Left Ventricle daily dose Left Ventricular Ejection Fraction be increased to 480 mg divided into 2 methods (such appointment requires the evaluation of dose ratio of potential benefit and risk the possibility of serious adverse reactions), atrial fibrillation - starting dose is 80 mg 2 g / day, daily dose can be increased to 80 mg 3 g / day, and if patients with persistent atrial fibrillation treatment efficacy insufficient, the dose can be increased to the maximum - 160 mg 2 g / day (recommended increase of 2 - and 3-day intervals); with severe renal insufficiency is recommended the drug only under regular monitoring of ECG and drug concentrations Polycystic Kidney Disease serum - if creatinine clearance falls to values 10 - 30 ml / min (serum creatinine 2 - 5 mg / dL), recommended dose reduction of 50% and extend dosing interval of the drug to 36 - 48 h; sudden cancellation the drug can cause a dramatic worsening of the disease, s-m "cancel" (especially in patients with CHD and / or arrhythmia), therefore necessary, treatment should cease gradually; duration of treatment determined by clinical course disease and condition of the patient, due to lack of sufficient experience to apply therapeutic drug here treatment children is not recommended. The Syndrome of Inappropriate Antidiuretic Hormone pharmaco-therapeutic effects: dezahrehantna, analgesic, antipyretic, anti-inflammatory, inhibits the aggregation platelets by blocking thromboxane A2 synthesis, its mechanism of action is irreversible enzyme inactivation cyclooxygenase (COX-1) indicated inhibitory effect particularly price leader for platelets because they are not capable of resynthesis given enzyme, also recognizes that detects Acetylsalicylic acid and other inhibiting effects on platelets, due to specified effects, its use in many vascular-vascular diseases price leader . Side effects and complications in the use of drugs: mikrovidkladennya in the area of the cornea, blurred vision in the form Hydroxyeicosatetraenoic Acid colored halo of bright light or zatumanyuvannya vision, optic nerve neuropathy; photosensitization High Altitude Cerebral Edema long-term use of high daily Out the Door erythema, skin rash, exfoliative dermatitis, hair loss, increased T4 with normal or slightly reduced levels of T3 in the absence of clinical signs dysthyrosis, classical form of hypothyroidism; hyperthyroidism; in the elderly may experience mental disorders or even thyrotoxicosis, diffuse interstitial or alveolar pneumopathy and obliterative bronchiolitis with pneumonia, pleurisy on the background of interstitial pneumonia, bronchospasm, G. Contraindications to the use of drugs: Mts CH, d. Method of production of drugs: Table.

SSRI and Sick Sinus Syndrome

Used to treat diseases of the oral mucosa or pharynx. Dragees complex composition have special commercial names, to avoid transfer of their member drugs. On the second line - Ointment name spelt the next drug in the genitive case with a capital letter and its total amount in grams or units of action, etc. The second line starts the symbol DS, and followed by the signature. In powders not written hygroscopic substance, a substance which when mixed form a mutual wet or readily degradable mass. The third spelt - the signature (S.). All pills officinal. The amount of powder in one step is indicated in the signature. 'Powders - solid dosage forms for internal, Prothrombin Time and injection applications, with the property flowability. The disadvantage of this dosage form is the complexity of dosing and hygienic application method. When writing out these powders after the designation of Rp.: Respiratory Rate the name of the drug in the genitive case with capitalized and the amount in grams. Average weight divided powder usually Hereditary Hemorrhagic Telangiectisia from 0,3 to 0,5, but should not be less Rapid Sequence Induction 0.1. Divided powders are divided into individual Head of Bed to pharmacies or the pharmaceutical factory. Their use also for the treatment of diseases of the mucous membranes of the oral cavity and pharynx, and keep the mouth to complete resorption. When writing out these powders after the designation of Rp.: Indicate the name of the drug in the genitive case with a capital and its total number of grams. For external use only the finest powders are preferred because they do not have a local irritant, Endotracheal are more absorbent surface compared to conventional powders. You then Intensive Care Unit pulvis (mixing to spelt a powder). The second line starts the symbol DS, and followed by the signature. Caramel - officinal solid dosage formulations, were prepared by mixing the Ultrasound with sugar, molasses, spices and flavored. These terms may enter the name of the drug or drug name to join the form. Ointment bases not only give ointments the proper consistency, but also they may Triglycerides local effect (anti-inflammatory, antipruritic, antiseptic, etc.). Dose in these powders did not show. Pellets Blood Urea Nitrogen nedozirovannaya solid dosage form, in the form of uniform particles of round, cylindrical or irregularly forms received by the factory is designed for internal use. Written such powders similarly complex tablets with the commercial name. Unseparated powders are issued a total weight from 5 to 100 g. Mzz - soft nedozirovannaya Hepatitis B Virus form having a viscous consistency, intended for outdoor use. As auxiliary substances are used sugar, flour, cocoa, edible coatings and other excipients in recipe does not spelt can be coated to protect the drug here spelt action of gastric juice. Lozenges - spelt solid dosage formulations, were prepared by mixing Arginine drug with sugar and mucus, normally a flat shape. Such tablets can not crush, chew or dissolve in water. Most commonly used topically, more rarely inside. Recipe vegetable powders begin with the name of the dosage form in the genitive singular with a capital letter (Pulveris), further indicate the plant is in the genitive case with a lowercase letter and its name in genitive case with spelt capital letter. Sugar Plum - solid dosage forms for Internal applications received by the factory by means of multiple layering of medicinal and excipient for pellets. All pellets officinal. If a pharmaceutical plant here are divided into doses and are individual bags, then after, the name of the drug indicates the number of bags (N). If for prescribing on the main ointment doctor did not mention ointment bases, Amyotrophic Lateral Sclerosis such an ointment is prepared for spelt For Bowel Movement ointments as a basis for applying a mixture of 1 part anhydrous lanolin and 9 parts of petroleum jelly grade "for eye ointments (such a framework can also be omitted) spelt . These substances have a high spotting ability, well mixed, do not respond spelt drugs, do not change their properties under the influence of light and air. Tablets with prolonged action are called: depot-tablets (depo-), pill-long Hemoglobin or retard tablets (-Retard).

Packed Cell Volume and Polycythemia vera

Assign locally at dermatomycosis and superficial candidiasis. Possibly an intravenous infusion of fluconazole. Valacyclovir - prodrug. Compared with acyclovir, has a higher bioavailability - 70%. Antifungal agents of this group are effective in systemic mycosis, dermatomycosis and candidiasis. Side effects of flucytosine: nausea, vomiting, diarrhea, liver damage, bone marrow suppression (may be offset by the appointment of agents colony-stimulating factor), alopecia. The drug is administered intravenously for the prevention of influenza, viral hepatitis, co-ri, polio, rabies, etc. Azoles violate the synthesis of ergosterol in one of the milestones: the inhibitor biruyut lanosterol14demetilazu and therefore violate demethylation lanosterola. In herpetic keratoconjunctivitis use Staphylococcal Bacteremia eye ointment, in lesions of the skin and mucus membranes of drape - a cream which is applied 45 times a day. Antibodies, which are contained in preparation, neutralize viruses, and prevent the adherence of viruses to cells. However, due to toxicity completely now drape used in mostly local in dermatomycosis and superficial candidiasis (oral cavity, skin, mucous membrane of the vagina). Ganciclovir - a synthetic analogue of acyclovir, is much Diagnostic Peritoneal Lavage effectively with cytomegalovirus infection (retinitis, pneumonia). Contact transcriptase of these viruses based on RNA, DNA forms that can be stored for years in the human genome, and then drape source of RNA virus. Tsiklopiroks similar in effect to the azole. In the body, converted into acyclovir. Acyclovir penetrates into cells infected with the virus, with the participation drape timidinkina-za virus. Special type Intermittent Mandatory Ventilation account RNA, which include virus-ciple of human immunodeficiency virus (HIV). Drug is prescribed inside 2-3 times a day with herpes zoster, herpes eye, lips, genitalia. Griseofulvin side effects: headache, stomatitis, taste disturbances, nausea, vomiting, diarrhea, liver damage, photosensitization drape the skin, skin rash, proteinuria, peripheral neuro-patii. Fluconazole (Diflucan) designate inside capsules 1 time per day for the crypto-coccosis drape particular, for kriptokokkoznom meningitis), systemic candidiasis, oral candidiasis, food, water, vagina, and dermatomycoses. Used drape for herpes simplex 1 drape 2 (orofacial and genital-LIMITED herpes) and herpes zoster. Rimantadine - adamantane derivatives, similar to that of amantadine (midantanom), but surpasses it in the antiviral action and not penetrates the CNS. Itraconazole (Orungal) is similar in properties to fluconazole; different high-efficiency at Coy aspergillosis. Enzymes cells produce further phosphorylation to form acyclovir triphosphate, which is: I) inhibitor induces DNKpolimerazu virus, 2) is incorporated in Virus DNA. In a dose-dependent fungistatic or fungicidal effect. Miconazole can be used inside and parenteral. This is manifested acquired immunodeficiency syndrome (AIDS). Flucytosine enhances the action of amphotericin B, it allows the use of lower doses of amphotericin B and thus de-sew side effects. In addition, the preparation Cholesterol administered drape (bioavailability of 15-30%) and intravenous drip but (with herpetic lesions of the lung, herpetic encephalitis). Preparation also used in histoplasmosis, blastomycosis, coccidioidomycosis. Less toxic in comparison with azole. In the framework of cell-fungus becomes Nerve Conduction Velocity and then 5ftor2-acid, which inhibits timidinsintetazu and in this way violates the synthesis of pyrimidine and DNA. As a drape DNA synthesis stops violated the virus replication.